Home / United States / Inhibikase Therapeutics, Inc. (IKT)
Inhibikase Therapeutics, Inc. (IKT)
Short position disclosed on October 15, 2026. FINRA register read on November 5, 2026.
FINRA publishes, twice a month, the number of shares sold short in each company. Their share of the stock is computed here on the count the company reports to the SEC, and this market appears in no ranking shared with the others.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | Shares sold short | Over the year | Since |
|---|---|---|---|---|
| Aggregated total | 19,626,184 shares | +1,364,768 shares | October 15, 2026 |
Get the moves on Inhibikase Therapeutics, Inc. (IKT) by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | Shares sold short | End of publication |
|---|---|---|---|
| October 15, 2026 | Aggregated total | 19,626,184 shares | still open |
| September 30, 2026 | Aggregated total | 19,430,194 shares | |
| September 15, 2026 | Aggregated total | 18,518,754 shares | |
| August 31, 2026 | Aggregated total | 19,489,554 shares | |
| August 14, 2026 | Aggregated total | 19,666,839 shares | |
| July 31, 2026 | Aggregated total | 19,135,668 shares | |
| July 15, 2026 | Aggregated total | 18,261,416 shares |
Download 7 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the United States
- Wolfspeed, Inc. (WOLF) 51.66%
- Ondas Inc. Common Stock (ONDS) 44.50%
- Hertz Global Holdings, Inc Com (HTZ) 40.11%
- Eos Energy Enterprises, Inc. C (EOSE) 38.24%
- Shoe Station Group, Inc. Commo (SHOE) 36.36%
- Serve Robotics Inc. Common Sto (SERV) 36.00%
- BIO-key International, Inc. Co (BKYI) 35.61%
- C4 Therapeutics, Inc. Common S (CCCC) 34.73%
- Capricor Therapeutics, Inc. Co (CAPR) 34.16%
- TripAdvisor, Inc. Common Stock (TRIP) 32.76%
- PureCycle Technologies, Inc. C (PCT) 32.47%
- FuelCell Energy, Inc. Common S (FCEL) 32.28%
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Inhibikase Therapeutics, Inc. (IKT), source FINRA, data as at October 15, 2026, https://www.quivad.com/action/inhibikase-therapeutics-inc-ikt
Embed the chart
<iframe src="https://www.quivad.com/embed/action/inhibikase-therapeutics-inc-ikt" width="600" height="280" title="Inhibikase Therapeutics, Inc. (IKT)" loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/inhibikase-therapeutics-inc-ikt"><img src="https://www.quivad.com/action/inhibikase-therapeutics-inc-ikt/badge.svg" alt="QuiVad, Inhibikase Therapeutics, Inc. (IKT)"></a>